Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

Condition:   Secondary Progressive Multiple Sclerosis Interventions:   Drug: Rituximab;   Drug: Glatiramer Acetate Sponsor:   Isfahan University of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials